SPIROLEPT 200 millions U/ml, suspension for injection in a pre-filled syringe. vaccine leptospires inactivated syringe, 1 ml
Active ingredients: LEPTOSPIRA ICTEROHAEMORRHAGIAE, INACTIVÉ
Commercialized according to BDPMDispensing in France: Prescription only
Suspension for injectionsyringe, 1 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SPIROLEPT 200 millions U/ml, suspension injectable en seringue préremplie. Vaccin leptospires inactivé
- Pharmaceutical form
- suspension injectable
- Route of administration
- sous-cutanée
- Presentation description
- 1 seringue(s) préremplie(s) en verre de 1 ml avec aiguille
- Marketing authorisation holder
- IMAXIO
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 26 May 1999
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64175998CIP73514716CIP133400935147165Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LEPTOSPIRA ICTEROHAEMORRHAGIAE, INACTIVÉsuspension | 200 000 000 U · une dose de 1mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.